Day: March 6, 2025

NEW YORK, March 06, 2025 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced its addition to the S&P Dow Jones Indices’ S&P/ASX 200 Index effective March 6, 2025 on the Australian Stock Exchange (ASX). The S&P/ASX 200 is recognized as the institutional investable benchmark in Australia. Index constituents are drawn from eligible companies listed on the ASX. The S&P/ASX 200 is designed to measure the performance of the 200 largest index-eligible stocks listed on the ASX by float-adjusted market capitalization. Representative, liquid, and tradable, it is widely considered Australia’s preeminent benchmark index. About Mesoblast Mesoblast (the Company) is a world leader in developing allogeneic (off-the-shelf) cellular...

HOUSTON, March 06, 2025 (GLOBE NEWSWIRE) — Intuitive Machines, Inc. (Nasdaq: LUNR, LUNRW) (“Intuitive Machines”) (“Company”), a leading space exploration, infrastructure, and services company, has announced the IM-2 mission lunar lander, Athena, landed on the Moon at approximately 11:30 a.m. CST and is currently operating on the surface of the Moon. Earlier today, Intuitive Machines and NASA held a joint press conference to share the latest mission and landing updates. The conference highlighted the progress of lunar operations and the continued collaboration between commercial and government partners in advancing space exploration.    Intuitive Machines expects to continue to provide updates on the mission via the Company’s IM-2 mission webpage and official X account. The press conference is available on the IM-2 mission webpage. About...

Dubai, March 06, 2025 (GLOBE NEWSWIRE) — Micropolis Holding Company (NYSE American: MCRP) (“Micropolis” or the “Company”), a robotics manufacturer based in the United Arab Emirates which specializes in developing autonomous mobile robots that utilize wheeled electric vehicle platforms and are equipped with autonomous driving capabilities, announced today the pricing of its underwritten initial public offering (the “Offering”) of 3,875,000 Ordinary Shares at a public offering price of $4.00 per share, for total gross proceeds of $15.5 million to the Company, before underwriting discounts and other offering expenses. The Ordinary Shares are expected to begin trading on the NYSE American under the ticker symbol “MCRP” on March 7, 2025. The Offering is expected to close on March 10, 2025, subject to satisfaction of customary closing...

Shelton, CT, March 06, 2025 (GLOBE NEWSWIRE) — Hubbell Incorporated (NYSE: HUBB) today announced that Bill Sperry, Chief Financial Officer, will appear at the J.P. Morgan 2025 Industrials Conference.  The event will be webcast and is scheduled to begin at 12:15PM ET on Tuesday, March 11, 2025. The live audio of the event will be available and can be accessed by visiting Hubbell’s Investor Relations section. You can also access this information by going to www.hubbell.com and selecting “Investors” from the options at the bottom of the page and then “Events/Presentations” from the drop-down menu. The audio will be archived 24 hours after the event and can be accessed by going to www.hubbell.com and selecting “Investors” from the options at the bottom of the page and then “Events/Presentations”...

IRVINE, Calif., March 06, 2025 (GLOBE NEWSWIRE) — Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that management will participate in a fireside chat at the Barclays 27th Annual Global Healthcare Conference on Tuesday, March 11th, at 8:00 a.m. / 11:00 a.m. ET. A live webcast and additional information can be accessed on the events section of the Tarsus website. The replay will be available on the Tarsus website within 48 hours and will be archived for a limited time. About Tarsus Pharmaceuticals, Inc.Tarsus Pharmaceuticals, Inc. applies proven science and new technology to revolutionize treatment for patients, starting with eye care. Tarsus is advancing its pipeline to address several diseases with high unmet need across a range of therapeutic categories, including eye care and infectious disease prevention. XDEMVY®...

AUDUBON, Pa., March 06, 2025 (GLOBE NEWSWIRE) — Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced it will participate in the 2025 Annual Meeting of the American Academy of Orthopedic Surgeons (AAOS) in San Diego, Calif., from March 10-14, 2025. Join Globus at booth #2517 to learn about the comprehensive Globus Medical product portfolio across Spine, Trauma, and Joint Reconstruction procedures; Enabling Technology; Power Tools; and Regenerative Biomaterials segments. Globus will be featuring one of its latest technology innovations, the ExcelsiusFlex™ surgical robotic navigation system for Total Knee Arthroplasty (TKA), alongside its Total Joints Arthroplasty implant portfolio*. Engineered to outperform, ExcelsiusFlex™ with TKA Application consolidates accuracy, procedural...